DK1003496T3 - Lægemiddel til behandling af prostatisk intraepitelial neoplasi - Google Patents

Lægemiddel til behandling af prostatisk intraepitelial neoplasi

Info

Publication number: DK1003496T3
Authority: DK; Denmark
Prior art keywords: intraepithelial neoplasia; drug; treatment; prostatic intraepithelial; prostate
Prior art date: 1998-05-07

Application number

DK99924157T

Other languages

Danish (da)

English (en)

Inventor

Mitchell S Steiner

Sharon Raghow

Original Assignee

Univ Tennessee Res Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-05-07

Filing date

1999-05-07

Publication date

2005-04-04

1999-05-07 Application filed by Univ Tennessee Res Corp filed Critical Univ Tennessee Res Corp

2005-04-04 Application granted granted Critical

2005-04-04 Publication of DK1003496T3 publication Critical patent/DK1003496T3/da

Links

208000021046 prostate intraepithelial neoplasia Diseases 0.000 title abstract 3
208000004965 Prostatic Intraepithelial Neoplasia Diseases 0.000 title 1
206010071019 Prostatic dysplasia Diseases 0.000 title 1
239000003814 drug Substances 0.000 title 1
229940079593 drug Drugs 0.000 title 1
206010060862 Prostate cancer Diseases 0.000 abstract 1
208000000236 Prostatic Neoplasms Diseases 0.000 abstract 1
IWEQQRMGNVVKQW-OQKDUQJOSA-N Toremifene citrate Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.C1=CC(OCCN(C)C)=CC=C1C(\C=1C=CC=CC=1)=C(\CCCl)C1=CC=CC=C1 IWEQQRMGNVVKQW-OQKDUQJOSA-N 0.000 abstract 1
230000002113 chemopreventative effect Effects 0.000 abstract 1
229940124443 chemopreventive agent Drugs 0.000 abstract 1
239000012627 chemopreventive agent Substances 0.000 abstract 1
229960004167 toremifene citrate Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Urology & Nephrology (AREA)
Engineering & Computer Science (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines Containing Plant Substances (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Steroid Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DK99924157T 1998-05-07 1999-05-07 Lægemiddel til behandling af prostatisk intraepitelial neoplasi DK1003496T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US8460298P	1998-05-07	1998-05-07
EP99924157A EP1003496B1 (en)	1998-05-07	1999-05-07	Medicament for treating prostate intraepithelial neoplasia

Publications (1)

Publication Number	Publication Date
DK1003496T3 true DK1003496T3 (da)	2005-04-04

Family

ID=22186034

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK99924157T DK1003496T3 (da)	1998-05-07	1999-05-07	Lægemiddel til behandling af prostatisk intraepitelial neoplasi

Country Status (26)

Country	Link
US (1)	US6265448B1 (cs)
EP (3)	EP1475087A3 (cs)
JP (2)	JP4482229B2 (cs)
AT (1)	ATE283043T1 (cs)
AU (1)	AU761435B2 (cs)
BG (1)	BG65597B1 (cs)
CA (1)	CA2323809C (cs)
CZ (1)	CZ300960B6 (cs)
DE (2)	DE1003496T1 (cs)
DK (1)	DK1003496T3 (cs)
EA (1)	EA003466B1 (cs)
ES (1)	ES2145730T3 (cs)
HR (1)	HRP20000729A2 (cs)
HU (1)	HUP0102068A3 (cs)
IL (3)	IL138437A0 (cs)
IS (2)	IS2213B (cs)
NO (1)	NO20005625L (cs)
NZ (1)	NZ527522A (cs)
PL (1)	PL207462B1 (cs)
PT (1)	PT1003496E (cs)
SI (1)	SI1003496T1 (cs)
SK (1)	SK16642000A3 (cs)
TR (1)	TR200003269T2 (cs)
UA (1)	UA74532C2 (cs)
WO (1)	WO1999056739A1 (cs)
YU (1)	YU68600A (cs)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6413533B1 (en) *	1998-05-07	2002-07-02	The University Of Tennessee Research Corporation	Method for chemoprevention of prostate cancer
US20040186185A1 (en) *	1998-05-07	2004-09-23	Steiner Mitchell S.	Method for treatment and chemoprevention of prostate cancer
SI1003496T1 (en) *	1998-05-07	2005-10-31	The University Of Tennessee Research Corporation	Medicament for treating prostate intraepithelial neoplasia
US6410043B1 (en) *	1998-05-07	2002-06-25	The University Of Tennessee Research Corporation	Method for chemoprevention of prostate cancer
US20040092602A1 (en) *	1998-05-07	2004-05-13	Steiner Mitchell S.	Method for treatment and chemoprevention of prostate cancer
US20030130316A1 (en) *	2000-03-20	2003-07-10	Steiner Mitchell S.	Method for chemoprevention of prostate cancer
AU7360700A (en) *	1999-09-09	2001-04-10	Androsolutions, Inc.	Methods and compositions for preventing and treating urinary tract disorders
US6642274B1 (en)	1999-09-09	2003-11-04	Gary W. Neal	Methods and compositions for preventing and treating prostate disorders
US7524866B2 (en) *	2001-11-29	2009-04-28	Gtx, Inc.	Prevention and treatment of androgen—deprivation induced osteoporosis
US20040213841A1 (en) *	2001-11-29	2004-10-28	Steiner Mitchell S	Methods for treating hot flashes and gynecomastia
US20070197664A1 (en) *	2001-11-29	2007-08-23	Steiner Mitchell S	Prevention and treatment of androgen-deprivation induced osteoporosis
US20050080143A1 (en) *	2001-11-29	2005-04-14	Steiner Mitchell S.	Treatment of androgen-deprivation induced osteoporosis
US20060269611A1 (en) *	2001-11-29	2006-11-30	Steiner Mitchell S	Prevention and treatment of androgen-deprivation induced osteoporosis
US20080249183A1 (en) *	2001-11-29	2008-10-09	Steiner Mitchell S	Treatment of androgen-deprivation induced osteoporosis
US20040096510A1 (en) *	2001-11-29	2004-05-20	Steiner Mitchell S.	Prevention and treatment of androgen-deprivation induced osteoporosis
MXPA04005112A (es)	2001-11-29	2005-04-29	Gtx Inc	Prevencion y tratamiento de osteoporosis inducida por privacion de androgeno.
US20040214898A1 (en) *	2001-11-29	2004-10-28	Steiner Mitchell S.	Methods for treating hot flashes
US7332525B2 (en) *	2003-01-17	2008-02-19	Castle Erik P	Method of treatment of prostate cancer and composition for treatment thereof
US7070816B2 (en) *	2003-12-05	2006-07-04	New Chapter, Inc.	Methods for treating prostatic intraepithelial neoplasia with herbal compositions
US20050208159A1 (en) *	2004-03-16	2005-09-22	Kang Kyung S	Phytoestrogenic composition comprising an extract of chinese licorice root, liquiritin or isoliquiritin
US20060019989A1 (en) *	2004-07-21	2006-01-26	Steiner Mitchell S	Compositions comprising 5-alpha reductase inhibitors and SERMs and methods of use thereof
US20060105045A1 (en) *	2004-11-08	2006-05-18	Buchanan Charles M	Cyclodextrin solubilizers for liquid and semi-solid formulations
WO2006052922A2 (en) *	2004-11-08	2006-05-18	Eastman Chemical Company	Pharmaceutical formulations of cyclodextrins and selective estrogen receptor modulator compounds
US20060270641A1 (en) *	2005-05-31	2006-11-30	Steiner Mitchell S	Method for chemoprevention of prostate cancer
USD969722S1 (en)	2021-09-28	2022-11-15	Wagner Delima	Stabilizing wedge pad

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4329364A (en)	1974-09-11	1982-05-11	Schering Corporation	Antiandrogenic agents and methods for the treatment of androgen dependent disease states
US4474813A (en)	1980-10-24	1984-10-02	Schering Corporation	Pharmaceutical preparations comprising flutamide
GB2126576B (en) *	1982-06-25	1985-06-19	Farmos Group Limited	Alkane and alkene derivatives
FI77839C (fi) *	1982-05-27	1989-05-10	Farmos Oy	Foerfarande foer framstaellning av nya terapeutiskt effektiva trifenylalkan- och alkenderivat.
US5491173A (en)	1982-06-25	1996-02-13	Orion-Yhtyma Oy	Tri-phenyl alkene derivatives and their preparation and use
US5595985A (en)	1989-03-10	1997-01-21	Endorecherche Inc.	Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia
US4990538A (en)	1989-08-23	1991-02-05	Harris Adrian L	Use of toremifene and its metabolites for the reversal of multidrug resistance of cancer cells against cytotoxic drugs
GB9126209D0 (en)	1991-12-10	1992-02-12	Orion Yhtymae Oy	Drug formulations for parenteral use
GB9207437D0 (en)	1992-04-03	1992-05-20	Orion Yhtymae Oy	Topical administration of toremifene and its metabolites
DK0671909T3 (da) *	1992-12-01	2001-03-19	Biotie Therapies Corp	Syndecanstimulering af cellulær differentiering
US5595722A (en)	1993-01-28	1997-01-21	Neorx Corporation	Method for identifying an agent which increases TGF-beta levels
DE69435137D1 (de)	1993-05-13	2008-10-16	Poniard Pharmaceuticals Inc	Prävention und behandlung von pathologien, die mit einer abnormalen proliferationglatter muskelzellen verbunden sind
CA2168584C (en)	1993-08-09	2008-10-14	Edward Baral	A method for sensitization of cancer cells for killer cell mediated lysis
US5650425A (en)	1994-04-04	1997-07-22	Pharmos Corporation	Permanently ionic derivatives of steroid hormones and their antagonists
US5629007A (en)	1995-03-21	1997-05-13	Eli Lilly And Company	Method of preventing prostatic cancer development
US5635197A (en)	1995-03-21	1997-06-03	Eli Lilly And Company	Treatment and prevention of prostatic cancer metastasis
ZA984650B (en) *	1997-06-19	1998-12-08	Orion Corp	Intratumoral administration of triphenylethylenes for the treatment of cancer
SI1003496T1 (en) *	1998-05-07	2005-10-31	The University Of Tennessee Research Corporation	Medicament for treating prostate intraepithelial neoplasia

1999
- 1999-05-07 SI SI9930740T patent/SI1003496T1/xx unknown
- 1999-05-07 ES ES99924157T patent/ES2145730T3/es not_active Expired - Lifetime
- 1999-05-07 EP EP04018861A patent/EP1475087A3/en not_active Withdrawn
- 1999-05-07 DK DK99924157T patent/DK1003496T3/da active
- 1999-05-07 EP EP10012242A patent/EP2277514A1/en not_active Withdrawn
- 1999-05-07 WO PCT/US1999/010146 patent/WO1999056739A1/en not_active Ceased
- 1999-05-07 EA EA200000100A patent/EA003466B1/ru not_active IP Right Cessation
- 1999-05-07 DE DE1003496T patent/DE1003496T1/de active Pending
- 1999-05-07 YU YU68600A patent/YU68600A/sh unknown
- 1999-05-07 AU AU40726/99A patent/AU761435B2/en not_active Ceased
- 1999-05-07 DE DE69922131T patent/DE69922131T2/de not_active Expired - Lifetime
- 1999-05-07 IL IL13843799A patent/IL138437A0/xx unknown
- 1999-05-07 CA CA002323809A patent/CA2323809C/en not_active Expired - Fee Related
- 1999-05-07 SK SK1664-2000A patent/SK16642000A3/sk unknown
- 1999-05-07 NZ NZ527522A patent/NZ527522A/xx unknown
- 1999-05-07 EP EP99924157A patent/EP1003496B1/en not_active Expired - Lifetime
- 1999-05-07 TR TR2000/03269T patent/TR200003269T2/xx unknown
- 1999-05-07 HU HU0102068A patent/HUP0102068A3/hu unknown
- 1999-05-07 US US09/306,958 patent/US6265448B1/en not_active Expired - Fee Related
- 1999-05-07 AT AT99924157T patent/ATE283043T1/de not_active IP Right Cessation
- 1999-05-07 CZ CZ20004118A patent/CZ300960B6/cs not_active IP Right Cessation
- 1999-05-07 JP JP2000546766A patent/JP4482229B2/ja not_active Expired - Lifetime
- 1999-05-07 HR HR20000729A patent/HRP20000729A2/hr not_active Application Discontinuation
- 1999-05-07 PT PT99924157T patent/PT1003496E/pt unknown
- 1999-05-07 PL PL344000A patent/PL207462B1/pl not_active IP Right Cessation
- 1999-07-05 UA UA2000116229A patent/UA74532C2/uk unknown
2000
- 2000-09-12 IL IL138437A patent/IL138437A/en not_active IP Right Cessation
- 2000-11-01 IS IS5700A patent/IS2213B/is unknown
- 2000-11-07 NO NO20005625A patent/NO20005625L/no not_active Application Discontinuation
- 2000-12-05 BG BG105022A patent/BG65597B1/bg unknown
2006
- 2006-03-15 IS IS8354A patent/IS8354A/is unknown
2008
- 2008-03-21 JP JP2008074318A patent/JP2008163048A/ja active Pending
- 2008-08-04 IL IL193231A patent/IL193231A0/en unknown

Also Published As

Publication number	Publication date
WO1999056739A1 (en)	1999-11-11
EA200000100A1 (ru)	2000-08-28
CZ20004118A3 (cs)	2002-07-17
IS5700A (is)	2000-11-01
ES2145730T3 (es)	2005-06-16
NO20005625L (no)	2001-01-05
YU68600A (sh)	2003-12-31
IL138437A (en)	2008-12-29
EP1475087A3 (en)	2007-07-11
DE69922131T2 (de)	2005-11-24
JP4482229B2 (ja)	2010-06-16
CA2323809A1 (en)	1999-11-11
EP1475087A2 (en)	2004-11-10
EP1003496B1 (en)	2004-11-24
SI1003496T1 (en)	2005-10-31
PL207462B1 (pl)	2010-12-31
IS8354A (is)	2006-03-15
AU761435B2 (en)	2003-06-05
PT1003496E (pt)	2005-04-29
AU4072699A (en)	1999-11-23
PL344000A1 (en)	2001-09-10
NO20005625D0 (no)	2000-11-07
EA003466B1 (ru)	2003-06-26
TR200003269T2 (tr)	2001-02-21
DE1003496T1 (de)	2000-11-02
IL138437A0 (en)	2001-10-31
ES2145730T1 (es)	2000-07-16
EP2277514A1 (en)	2011-01-26
SK16642000A3 (sk)	2002-08-06
DE69922131D1 (de)	2004-12-30
HRP20000729A2 (en)	2001-06-30
IS2213B (is)	2007-03-15
HUP0102068A3 (en)	2002-11-28
EP1003496A1 (en)	2000-05-31
BG105022A (bg)	2001-07-31
US6265448B1 (en)	2001-07-24
UA74532C2 (en)	2006-01-16
JP2002513755A (ja)	2002-05-14
ATE283043T1 (de)	2004-12-15
JP2008163048A (ja)	2008-07-17
BG65597B1 (bg)	2009-02-27
CZ300960B6 (cs)	2009-09-23
CA2323809C (en)	2007-09-18
NZ527522A (en)	2005-04-29
HUP0102068A2 (hu)	2002-05-29
IL193231A0 (en)	2009-02-11

Publication	Publication Date	Title
PT1003496E (pt)	2005-04-29	Medicamento para tratamento de neoplasia intra-epitelial prostatica
BR9806118A (pt)	1999-08-31	Processos para tratamento de pigmentação de pele
EP2261200A3 (en)	2010-12-29	Modified forms of pharmacacologically active agents and uses therefor
AU2002236765A1 (en)	2002-07-30	Pharmaceutical combination for the treatment of cancer containing a 4-quinazolineamine and another anti-neoplastic agent
NZ516349A (en)	2004-03-26	Conjugates of phytosterol or phytostanol with ascorbic acid and use thereof in treating or preventing cardiovascular disease
AU2001287892A1 (en)	2002-04-02	Use of glp -2 in combination with another therapeutic agent in bone-related and nutrition-related disorders
BR9812122A (pt)	2000-07-18	Combinação de inibidor da tirosina quinase e castração quìmica para tratar câncer da próstata
EP0943331A3 (en)	1999-11-03	Formulations containing oxaliplatin
TWI315987B (en)	2009-10-21	The use of toremifene for the prevention and treatment of androgen-deprivation induced osteoporosis, loss of bone mineral density and/or bone fractures in males subjects with prostate cancer
IS4972A (is)	1999-02-10	Notkun klóbindiefnisins klíókínól við að framleiða lyfjablöndu til að meðhöndla Alzheimers-sjúkdóm
IL143901A0 (en)	2002-04-21	Use of cyclooxygenase-2- inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combination treatment of neoplasia
AU2002321105A1 (en)	2002-12-16	Use of hepcidin for preparing a medicament for treating disorders of iron homeostasis
IS6970A (is)	2003-09-29	Lyfjablanda á föstu formi sem felur í sér 4-sýanó-tríflúor-3-(4-flúorfenýlsúlfonýl)-2-hýdroxý-2-metýlprópíón-m-tólúidíð og PVP
IL155263A0 (en)	2003-11-23	Pharmaceutical solutions of modafinil compounds
IL125776A (en)	2003-12-10	Use of a cimicifuga racemosa extract for the manufacture of a drug for treating estrogen-dependent tumors
EP1743656A3 (en)	2007-03-07	Pharmaceutical combination for the treatment of benign prostatic hyperplasia or for the long-term prevention of acute urinary retention
BR0109789A (pt)	2003-01-21	Método para o tratamento de câncer de mama, e, uso de fulvestrante
BR0115882A (pt)	2003-12-02	Emprego de compostos de 1-fenil-3-dimetilaminopropano no tratamento da incontinência urinária
PL357179A1 (en)	2004-07-26	Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid (2-mtdc) and/or physiologically compatible salts for treating and/or preventing cancers
DE59101818D1 (de)	1994-07-14	Arzneimittelzubereitung, enthaltend Stigmasta-4-en-3-on sowie deren Verwendung.
WO2002056755A3 (en)	2002-09-26	Method for treating cancer
SE0101697D0 (sv)	2001-05-14	Pharmaceutical combination
DE59915118D1 (de)	2010-02-11	Stabile zubereitungen mit hyperforin
GEP20043311B (en)	2003-11-10	Combination for Prevention of Bleeding and TUR-Syndrome during Transurethral Resection of Prostate
BR9908664A (pt)	2001-06-26	O uso do nitroprussiato de sódio e a respectiva aplicação